Neuronexus

Nonprofit profile at a glance

EIN
760334402
IRS 990 coverage
2013–2023
Forms available
Form 990 2023
Location
College Grove, TN, USA
Phone
6157915470
Rating confidence
Limited
Sector
Federated Giving Programs

Reported finances

Revenue
$0
Expenses
$2,672
Assets
$14,305
Liabilities
$16,040

Source: IRS Form 990. Selected filing: tax year 2023. Amounts in USD.

Leadership & pay

3 people listed

People named in this filing

  • AMY BROWN (SECRETARY)
  • DR DANIEL KANTOR (CHAIRMAN)
  • RANDOLPH QUIGLEY (BOARD MEMBER)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2023. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Neuronexus is a public name for the novel pharmaceutics institute, a 501 (c)3 charitable organization for these purposes: provide a public forum and medical education and research specifically focused on neurosciences. Principle goals are to enhance the local and regional access of students to neuroscience expertise, provide expertise to the pharmaceutical industry, and support local research missions for treatment and diagnosis of neurological disease.

What it reported doing in 2023

Medical education, continuing education grants, medical research, training physicians in use of medication, public information, public education on neurological disease, grants for continuing education and exposure to education opportunities for students, educational benefits for students, training for medical related student activity, internships, mentorships and training for individuals, youths and students in health care professions. Dr. Daniel kantor, chairman of the board, operates the affiliated group, medical partnership for ms.

Operating model

Revenue model
No positive adjusted resources. The filing reports no positive adjusted operating resources.
Distribution model
No current program activity. The filing reports no program spending for the current year.

The verdict

- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.

Rating breakdown

  • Financial Efficiency: 0
  • Transparency & Controls: 90
  • Accountability: 70
  • Sustainability: 22
  • Growth: 0

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: Limited
  • Program expense ratio: 0%; rating input score 0
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
  • Governance controls: 2 of 7 controls in place; rating input score 29
    • Conflict-of-interest policy: Fail
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: Limited
  • Total-asset coverage ratio: 5.35; rating input score 49; 49th percentile among comparable filings
  • Liabilities to assets ratio: 1.12; rating input score 4; 4th percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 60; 60th percentile among comparable filings

Growth

  • Program expense growth: -26% per year; rating input score 0; 14th percentile among comparable filings
  • Revenue growth: -28% per year; rating input score 0; 15th percentile among comparable filings
  • Asset growth: -7.7% per year; rating input score 0; 16th percentile among comparable filings

Details

  • Where the money goes: 0% of spending went to programs
  • Governance: 3 of 3 board members independent · 2 of 7 filing controls reported
  • Programs: 1 filed program accomplishment
  • Leadership: top reported pay $0 · 3 people listed
  • Consistency: 13 of 13 current checks pass
  • Schedules: 4 filed schedules
  • Filing history: 10 filing years from 2013 to 2023
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Financial Efficiency: Program expense ratio scored 0/100.
  • High — Accountability: Governance controls: 4 of 6 not reported.
  • High — Growth: Program expense growth scored 0/100.
  • High — Growth: Revenue growth scored 0/100.
  • Moderate — Sustainability: Total-asset coverage ratio scored 49/100.
  • High — Sustainability: Liabilities to assets ratio scored 4/100.
  • High — Growth: Asset growth scored 0/100.